Nuovi sistemi per la prevenzione del rischio cardioembolico in pazienti con fibrillazione atriale: Una revisione sistematica della letteratura sulla chiusura percutanea dell'auricola sinistra

Translated title of the contribution: New systems for the prevention of cardioembolic risk in patients with atrial fibrillation: A systematic review of the literature on percutaneous left atrial appendage closure

Paolo Danna, Antonio Sagone, Riccardo Proietti, Andrea Arensi, Maurizio Viecca, Pasquale Santangeli, Luigi Di Biase, Andrea Natale

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Atrial fibrillation (AF) is the most common cardiac arrhythmia. The mortality rate of patients with AF is doubled as compared to non-fibrillating controls. The most relevant complication of AF is a major increase in the risk of stroke. The gold standard in reducing cerebrovascular events in AF is warfarin therapy, which is not free from contraindications and limitations. The left atrial appendage (LAA) is the main source of emboli causing stroke in AF. LAA closure is a seducing approach to stroke risk reduction in AF without anticoagulation. Since 1949, heart surgeons have performed LAA closure or amputation in patients with AF. Percutaneous endovascular LAA closure is a new, less invasive, technique to reach the goal. Several devices have been used to perform this intervention, and the results of published trials are encouraging in terms of effectiveness and relative safety of this attractive technique. In this review we examine the published trials and data on percutaneous LAA closure, with particular attention to the risks and benefits of this procedure.

Original languageItalian
Pages (from-to)571-582
Number of pages12
JournalGiornale Italiano di Cardiologia
Volume13
Issue number9
DOIs
StatePublished - Sep 2012
Externally publishedYes

Fingerprint

Atrial Appendage
Atrial Fibrillation
Stroke
Warfarin
Risk Reduction Behavior
Embolism
Amputation
Cardiac Arrhythmias
Safety
Equipment and Supplies
Mortality

Keywords

  • Atrial fibrillation
  • Left atrial appendage closure
  • Stroke

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Nuovi sistemi per la prevenzione del rischio cardioembolico in pazienti con fibrillazione atriale : Una revisione sistematica della letteratura sulla chiusura percutanea dell'auricola sinistra. / Danna, Paolo; Sagone, Antonio; Proietti, Riccardo; Arensi, Andrea; Viecca, Maurizio; Santangeli, Pasquale; Di Biase, Luigi; Natale, Andrea.

In: Giornale Italiano di Cardiologia, Vol. 13, No. 9, 09.2012, p. 571-582.

Research output: Contribution to journalArticle

Danna, Paolo ; Sagone, Antonio ; Proietti, Riccardo ; Arensi, Andrea ; Viecca, Maurizio ; Santangeli, Pasquale ; Di Biase, Luigi ; Natale, Andrea. / Nuovi sistemi per la prevenzione del rischio cardioembolico in pazienti con fibrillazione atriale : Una revisione sistematica della letteratura sulla chiusura percutanea dell'auricola sinistra. In: Giornale Italiano di Cardiologia. 2012 ; Vol. 13, No. 9. pp. 571-582.
@article{483c4b435fc0439a9dd5a709ed2eb406,
title = "Nuovi sistemi per la prevenzione del rischio cardioembolico in pazienti con fibrillazione atriale: Una revisione sistematica della letteratura sulla chiusura percutanea dell'auricola sinistra",
abstract = "Atrial fibrillation (AF) is the most common cardiac arrhythmia. The mortality rate of patients with AF is doubled as compared to non-fibrillating controls. The most relevant complication of AF is a major increase in the risk of stroke. The gold standard in reducing cerebrovascular events in AF is warfarin therapy, which is not free from contraindications and limitations. The left atrial appendage (LAA) is the main source of emboli causing stroke in AF. LAA closure is a seducing approach to stroke risk reduction in AF without anticoagulation. Since 1949, heart surgeons have performed LAA closure or amputation in patients with AF. Percutaneous endovascular LAA closure is a new, less invasive, technique to reach the goal. Several devices have been used to perform this intervention, and the results of published trials are encouraging in terms of effectiveness and relative safety of this attractive technique. In this review we examine the published trials and data on percutaneous LAA closure, with particular attention to the risks and benefits of this procedure.",
keywords = "Atrial fibrillation, Left atrial appendage closure, Stroke",
author = "Paolo Danna and Antonio Sagone and Riccardo Proietti and Andrea Arensi and Maurizio Viecca and Pasquale Santangeli and {Di Biase}, Luigi and Andrea Natale",
year = "2012",
month = "9",
doi = "10.1714/1133.12485",
language = "Italian",
volume = "13",
pages = "571--582",
journal = "Giornale Italiano di Cardiologia",
issn = "1827-6806",
publisher = "CEPI s.r.l.",
number = "9",

}

TY - JOUR

T1 - Nuovi sistemi per la prevenzione del rischio cardioembolico in pazienti con fibrillazione atriale

T2 - Una revisione sistematica della letteratura sulla chiusura percutanea dell'auricola sinistra

AU - Danna, Paolo

AU - Sagone, Antonio

AU - Proietti, Riccardo

AU - Arensi, Andrea

AU - Viecca, Maurizio

AU - Santangeli, Pasquale

AU - Di Biase, Luigi

AU - Natale, Andrea

PY - 2012/9

Y1 - 2012/9

N2 - Atrial fibrillation (AF) is the most common cardiac arrhythmia. The mortality rate of patients with AF is doubled as compared to non-fibrillating controls. The most relevant complication of AF is a major increase in the risk of stroke. The gold standard in reducing cerebrovascular events in AF is warfarin therapy, which is not free from contraindications and limitations. The left atrial appendage (LAA) is the main source of emboli causing stroke in AF. LAA closure is a seducing approach to stroke risk reduction in AF without anticoagulation. Since 1949, heart surgeons have performed LAA closure or amputation in patients with AF. Percutaneous endovascular LAA closure is a new, less invasive, technique to reach the goal. Several devices have been used to perform this intervention, and the results of published trials are encouraging in terms of effectiveness and relative safety of this attractive technique. In this review we examine the published trials and data on percutaneous LAA closure, with particular attention to the risks and benefits of this procedure.

AB - Atrial fibrillation (AF) is the most common cardiac arrhythmia. The mortality rate of patients with AF is doubled as compared to non-fibrillating controls. The most relevant complication of AF is a major increase in the risk of stroke. The gold standard in reducing cerebrovascular events in AF is warfarin therapy, which is not free from contraindications and limitations. The left atrial appendage (LAA) is the main source of emboli causing stroke in AF. LAA closure is a seducing approach to stroke risk reduction in AF without anticoagulation. Since 1949, heart surgeons have performed LAA closure or amputation in patients with AF. Percutaneous endovascular LAA closure is a new, less invasive, technique to reach the goal. Several devices have been used to perform this intervention, and the results of published trials are encouraging in terms of effectiveness and relative safety of this attractive technique. In this review we examine the published trials and data on percutaneous LAA closure, with particular attention to the risks and benefits of this procedure.

KW - Atrial fibrillation

KW - Left atrial appendage closure

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=84864883071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864883071&partnerID=8YFLogxK

U2 - 10.1714/1133.12485

DO - 10.1714/1133.12485

M3 - Article

C2 - 22825342

AN - SCOPUS:84864883071

VL - 13

SP - 571

EP - 582

JO - Giornale Italiano di Cardiologia

JF - Giornale Italiano di Cardiologia

SN - 1827-6806

IS - 9

ER -